A cell line derived from non-neoplastic human neuroretinal cells

Area of Science:

• Ophthalmology and Cell Biology
• Retinal cell line development
• Prematurity-related ocular conditions

Background:

• Retinopathy of prematurity (ROP) is a leading cause of blindness in premature infants.
• Establishing stable human retinal cell lines is crucial for studying ROP pathogenesis.
• Previous research has focused on animal models or less characterized cell types.

Observation:

• A novel cell line was successfully derived from an epiretinal membrane of a Stage 5 ROP patient.
• Early passages showed cells with both neuronal (NSE+) and glial (GFAP+) markers, indicating potential bipotential characteristics.
• Cells exhibited diverse morphologies, including polygonal and spindly forms, and produced extracellular matrix components like collagen IV, laminin, and fibronectin.

Findings:

• The cell line possesses a diploid human karyotype (46, XX) and has been maintained for over 14 months and 20 passages.
• Cloned cell populations initially expressed NSE and GFAP, with some cells positive for keratin and negative for muscle actin and Factor VIII.
• In later passages, cells lost NSE/GFAP expression, became uniformly keratin-positive, and developed a consistent polygonal morphology with nonmotile cilia.

Implications:

• This unique human retinal cell line offers a valuable model for investigating normal human retinal cell development.
• It can be utilized to study the cellular and molecular mechanisms underlying retinopathy of prematurity and other retinal pathologies.
• The cell line's characteristics may facilitate research into therapeutic interventions and drug responses in retinal diseases.